Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business ...

Major pharmaceutical companies are increasingly turning to artificial intelligence (AI) to streamline patient selection for clinical trials and reduce the number of participants needed, consequently ...

No longer a far-off futuristic idea, artificial intelligence technology has seen its popularity skyrocket in recent years. | ...

An industry insider offers a close look at the bold claims and big money behind pharma's AI revolution. A recent article in ...

Boston, MA – The much-anticipated RE•WORK AI in Healthcare & Pharma Summit is set to take place on November 13-14, 2024, at ...

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

Pharma Industry Awards 2024 organiser BusinessRiver, asks senior Cognizant managers for their predictions for the year ahead.

Fierce Pharma’s Andrea Park and Ben Adams talk about major trends from the event that came up in conversations, including the ...

That will force the way pharma goes to market if you’re going to have a successful launch.” Compared to years past, when certain buzzwords like “AI” or “CTV” reigned supreme, DPE 2024 is shaking out ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

The Draghi report aimed at reinvigorating Europe’s economy as a whole, outlines his proposals to help the pharmaceutical ...